Sanjivani Paranteral Limited (BOM:531569)
India · Delayed Price · Currency is INR 192.35
-3.25 (-1.66%)
At close: Aug 17, 2026
Sanjivani Paranteral Market Cap
Sanjivani Paranteral has a market cap or net worth of 2.36 billion as of August 17, 2026. Its market cap has decreased by -8.21% in one year.
Market Cap
2.36B
Enterprise Value
2.52B
Revenue
747.28M
Ranking
n/a
PE Ratio
31.77
Stock Price
192.35
ChartMarket Cap Chart
Since October 17, 2007, Sanjivani Paranteral's market cap has increased from 200.84M to 2.36B, an increase of 1,076.52%. That is a compound annual growth rate of 13.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 2.36B | -16.93% |
| Dec 31, 2025 | 2.84B | -38.37% |
| Dec 31, 2024 | 4.62B | 119.33% |
| Dec 29, 2023 | 2.10B | 441.05% |
| Dec 30, 2022 | 388.93M | 3.46% |
| Dec 31, 2021 | 375.94M | 526.71% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 2, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BDH Industries | 3.14B |
| Medicamen Biotech | 3.06B |
| Astonea Labs | 2.92B |
| Everest Organics | 2.81B |
| Gennex Laboratories | 2.63B |
| Oxygenta Pharmaceutical | 2.42B |
| Accretion Pharmaceuticals | 2.12B |
| Coral Laboratories | 2.05B |